Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry tracks PEF ablation in 1,000 patients

NCT ID NCT05851430

Knowledge-focused Sponsor: Galvanize Therapeutics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This observational registry will follow 1,000 people who receive pulsed electric field (PEF) ablation for soft tissue lesions. The goal is to see how doctors use the device in everyday practice and to monitor safety. Participants will be treated per standard care and followed for outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pulsed electric field (PEF) ablation device
What this could lead to
If successful, this registry could provide real-world data on how well PEF ablation works and its safety, potentially guiding better use of this technology for soft tissue lesions.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by differences in patient care. It does not test a new treatment but rather collects existing practice data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who have had or who are scheduled to have soft tissue ablated by the Galvanize PEF technology

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subject will undergo or has undergone PEF energy delivery utilizing Galvanize technology 2. Subject is expected to be available for follow-up per the enrolling physician's standard care practices 3. For prospective cohort, subject has a life expectancy of at least 3 months; for retrospective cohort, subject has completed at least three months of imaging following the PEF procedure 4. Signed informed consent is obtained, if required by IRB Exclusion Criteria: None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Soft tissue lesion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

soft tissue neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Soft tissue lesion

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AnMed Health

    RECRUITING

    Anderson, South Carolina, 29621, United States

  • Banner Health

    RECRUITING

    Gilbert, Arizona, 85234, United States

  • Duke University Hospital

    RECRUITING

    Durham, North Carolina, 27705, United States

  • Eisenhower Medical Center

    RECRUITING

    Rancho Mirage, California, 92270, United States

  • Lankenau Institute for Medical Research (LIMR)

    RECRUITING

    Wynnewood, Pennsylvania, 19096, United States

  • Methodist Hospital

    RECRUITING

    San Antonio, Texas, 78229, United States

  • NCH Baker

    RECRUITING

    Naples, Florida, 34102, United States

  • New York Presbyterian Langone Health

    RECRUITING

    New York, New York, 10016, United States

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

  • University of Texas-Tyler

    RECRUITING

    Tyler, Texas, 75708, United States

  • West Virginia University

    RECRUITING

    Morgantown, West Virginia, 26506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.